Focus Taiwan App
Download

Gout medication Enpurol Y.C. recalled due to efficacy concerns

05/17/2023 08:50 PM
To activate the text-to-speech service, please first agree to the privacy policy below.

The makers of the gout medicine Enpurol Y.C. have issued a recall for a batch of around 230,000 tablets over efficacy concerns, Taiwan's Food and Drug Administration (FDA) said Wednesday.


(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)

    We value your privacy.
    Focus Taiwan (CNA) uses tracking technologies to provide better reading experiences, but it also respects readers' privacy. Click here to find out more about Focus Taiwan's privacy policy. When you close this window, it means you agree with this policy.
    62